| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/03/1997 | CA2233167A1 Method for transferring genes to the heart using aav vectors |
| 04/03/1997 | CA2232138A1 Alpha 1b adrenergic receptor antagonists |
| 04/03/1997 | CA2230121A1 Product and process to regulate actin polymerization |
| 04/02/1997 | EP0765878A1 Heterocyclic aryl-, alkyl- and cycloalkylacetic acid amides |
| 04/02/1997 | EP0765867A1 Substituted benzoyl guanidines, process for their preparation, their use as antiarrhythmics or diagnostic agent as well as pharmaceuticals containing them |
| 04/02/1997 | EP0765668A1 Extract of Iridaceas and composition containing it |
| 04/02/1997 | EP0765659A1 Delayed drug-releasing microspheres |
| 04/02/1997 | EP0765342A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 04/02/1997 | EP0765328A1 Pirydyl imidazole derivatives and processes for the preparation thereof |
| 04/02/1997 | EP0765326A1 Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 04/02/1997 | EP0765325A1 Novel 1,1-bis(heteroazolyl)alkane derivatives and their use as neuroprotective agents |
| 04/02/1997 | EP0765320A1 Benzimidazolone derivatives with central dopaminergic activity |
| 04/02/1997 | EP0765314A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 04/02/1997 | EP0765312A1 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors of cholesterol absorption |
| 04/02/1997 | EP0765311A1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines |
| 04/02/1997 | EP0765308A1 Enzyme inhibitors |
| 04/02/1997 | EP0765172A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 04/02/1997 | EP0736021A4 Polymorphs of losartan and the process for the preparation of form ii of losartan |
| 04/02/1997 | EP0622076B1 Inhibitor for restenosis after percutaneous coronary arterioplasty |
| 04/02/1997 | EP0587625B1 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1,4-benzodioxine and the process of preparation thereof |
| 04/02/1997 | EP0573465B1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 04/02/1997 | CN1146765A Use of imidazole derivatives for treating disorders involving angiotensin receptors AT 1 and AT2, certain such products preparation thereof, use thereof as drugs, and pharmaceutical composition contai |
| 04/02/1997 | CN1146458A Cardiovascular active polypeptide and its synthesis and medical use |
| 04/02/1997 | CN1146349A Traditional Chinese pharmacist-prepared medicine for hypertension and preparation method |
| 04/02/1997 | CN1146340A Medicine for curing cerebrovascular, cardiovascular and peripheral vascular diseases and production process |
| 04/02/1997 | CN1034415C Method for prepn. of novel ascorbic acid derivatives |
| 04/01/1997 | US5616691 Process for producing albumin preparation |
| 04/01/1997 | US5616684 Cyclic hexapeptide containing aspartic acid and derivatives, 2-thienylglycine, leucine, and tryptophan; endothelin receptor antagonist |
| 04/01/1997 | US5616620 Amino acid derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of obesity |
| 04/01/1997 | US5616608 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 04/01/1997 | US5616596 Substituted arylalkynyl-and heteroarylalkynl-N-hydroxyurea inhibitors of leukotriene biosynthesis |
| 04/01/1997 | US5616592 Useful for disorders of cardiovascular, gastrointestinal and psychological disorders |
| 04/01/1997 | US5616586 Tricyclic quinoxalinediones |
| 03/30/1997 | CA2186561A1 Heterocyclic aryl-, alkyl and cycloalkylacetamides |
| 03/28/1997 | CA2186580A1 Substituted benzoylguanidines, a process for their preparation, their use as medicament or diagnostic agent, and medicament comprising them |
| 03/27/1997 | WO1997011163A1 Pskh-1 ribozymes and uses in disease treatment |
| 03/27/1997 | WO1997011091A1 Novel peptide compounds and medicinal compositions thereof |
| 03/27/1997 | WO1997011090A1 Inhibition of tumor growth |
| 03/27/1997 | WO1997010840A1 Anti-inflammatory antisense drug |
| 03/27/1997 | WO1997010828A1 Therapy for tissue membrane insufficiency |
| 03/27/1997 | WO1997010824A1 Use of 5ht1b receptor antagonist for the treatment of vascular disease |
| 03/27/1997 | WO1997010712A1 Inhibition of tumor necrosis factor alpha |
| 03/27/1997 | CA2232301A1 Pskh-1 ribozymes and uses in disease treatment |
| 03/26/1997 | EP0764647A1 Substituted xanthins |
| 03/26/1997 | EP0764163A1 Tachykinin (nk 1) receptor antagonists |
| 03/26/1997 | EP0764162A1 Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants |
| 03/26/1997 | EP0764157A1 Benzopyrans and their use as therapeutic agents |
| 03/26/1997 | EP0723445B1 Analgesic agent and its use |
| 03/26/1997 | EP0662975B1 2-substituted adenosines with a-2 receptor affinity |
| 03/26/1997 | CN1146207A Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/26/1997 | CN1146157A Fibrin-specific antibody for use as an antithrombrotic agent |
| 03/26/1997 | CN1145899A Substituted guanidine cinnamate, its prepn., its application as medicine or diagnosing agent and medicine containing the compound |
| 03/26/1997 | CN1145894A New arylalkyl (thio) carboxamides, processes for preparing them and pharmacetuical compositions containing them |
| 03/26/1997 | CN1145809A Medicine for prevention and treatment of deficient blood-reperfusion disturbance |
| 03/26/1997 | CA2186086A1 Substituted xanthines |
| 03/25/1997 | US5614625 Collagenase inhibitors |
| 03/25/1997 | US5614615 Sialyl Lewis X mimetics incorporating fucopeptides |
| 03/25/1997 | US5614550 Anticholesterol agents or arteriosclerosis agents for humans |
| 03/25/1997 | US5614542 Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use |
| 03/25/1997 | US5614541 Pharmacologically active catechol derivatives |
| 03/25/1997 | US5614535 Adhesion receptor antagonists |
| 03/25/1997 | US5614534 Derivatives of β, β-dimethyl-4-piperidineethanamine as inhibitors of the cholesterol biosynthesis |
| 03/25/1997 | US5614531 Adhesion receptor antagonists |
| 03/25/1997 | US5614530 Gmp phosphodiesterase inhibitor, hypotensive |
| 03/25/1997 | US5614521 Nerve growth factor |
| 03/25/1997 | US5614516 12-aminopyridazinopyrroloisoquinoline compounds |
| 03/25/1997 | US5614508 Antiischemic agents, alzheimers, stroke or nervous system disorders |
| 03/25/1997 | US5614493 Administering in a zymogen form |
| 03/25/1997 | US5614490 Administration of low dose hemoglobin to increase perfusion |
| 03/25/1997 | US5614214 Incorporating lipid, reducing blood pressure decrease |
| 03/25/1997 | CA2139109C Purinone antianginal agents |
| 03/25/1997 | CA2092287C Controlled release verapamil tablet |
| 03/20/1997 | WO1997010361A1 Method for modulating cell apoptosis |
| 03/20/1997 | WO1997010334A2 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 03/20/1997 | WO1997010265A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/20/1997 | WO1997010256A1 Tetracyclic triterpenes as cholesterol-lowering and anti-atherosclerosis agents |
| 03/20/1997 | WO1997010254A1 Oligomers which inhibit expression of collagen genes |
| 03/20/1997 | WO1997010238A1 Quinolein-2(1h)-one derivatives as serotonin antagonists |
| 03/20/1997 | WO1997010211A1 Novel human nk3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 03/20/1997 | WO1997010210A1 Tricyclic pyrrolidine derivatives as calcium channel antagonists |
| 03/20/1997 | WO1997009981A1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 03/20/1997 | CA2232089A1 Oligomers which inhibit expression of collagen genes |
| 03/20/1997 | CA2232043A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/20/1997 | CA2232007A1 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidine derivatives as human nk3 receptor selective antagonists |
| 03/20/1997 | CA2231685A1 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 03/20/1997 | CA2231433A1 Method for modulating cell apoptosis |
| 03/19/1997 | EP0763598A1 Method of preparing a fusion protein |
| 03/19/1997 | EP0763597A2 Use of cytohesin-PH peptides to influence the adhesion capability of integrins |
| 03/19/1997 | EP0763541A1 11-(Substituted phenyl)-estra-4,9-diene derivatives |
| 03/19/1997 | EP0763536A1 Process for producing 6-aminomethyl-substituted quinoline-benzoic acids |
| 03/19/1997 | EP0763535A1 Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as pharmacological active CNS compounds |
| 03/19/1997 | EP0763527A1 Substituted 2,2-dimethyl-omega-phenoxy alkanoic acids and esters, process for their preparation and pharmaceutical compositions containing them |
| 03/19/1997 | EP0763524A1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use |
| 03/19/1997 | EP0763120A1 Safe vectors for gene therapy |
| 03/19/1997 | EP0763116A1 Recombinant viruses, preparation and use thereof in gene therapy |
| 03/19/1997 | EP0763106A1 Methods and compositions for treatment of restenosis and cancer using ribozymes |
| 03/19/1997 | EP0763039A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 03/19/1997 | EP0763035A1 Endothelin receptor antagonists |
| 03/19/1997 | EP0763033A1 Imidazole derivatives and processes for the preparation thereof |
| 03/19/1997 | EP0763032A1 Palladium catalyzed ring closure of triazolyl tryptamine |